Topas tackles $26m series B

Oct 20, 2020 • Thierry Heles

Topas Therapeutics, which is exploiting University of Hamburg research, has pocketed $26m in its series B round.

Topas Therapeutics, a Germany-based developer of treatments for autoimmune diseases based on research at University of Hamburg, closed a €22m ($26m) series B round yesterday co-led by Vesalius BioCapital III and BioMedPartners.
All existing shareholders – EMBL Ventures, the investment arm of European Molecular Biology Laboratory, commercialisation firm Epidarex Capital, drug discovery company Evotec, pharmaceutical firm Boehringer Ingelheim’s Venture Fund and Gimv – participated.
Founded in 2003, Topas Therapeutics is working on therapies for autoimmune diseases. Its lead…

Thierry Heles

Thierry Heles is the former editor-at-large of Global University Venturing and Global Corporate Venturing, and was the producer and host of the Beyond the Breakthrough podcast until December 2024.

Email LinkedIn

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

Cash-strapped UK universities explore joint tech transfer to save money, increase output

Pooling tech transfer resources could help smaller universities commercialise technology that they can't push out on their own.

12 groundbreaking global university spinouts that raised funding in 2024

Our pick of spinout technologies that are breaking new ground in plastics recycling, data storage, photonics, semiconductor materials and decoding the genome.

8 tips for investing in Japan’s university spinouts

Japan has a well-funded and vibrant market for deep tech companies spun out of its universities. Here are some of the quirks that foreign investors seeking to dip a toe into the sector should look out for.

Events

Webinar: Designing a winning CVC platform – Engagement, venture development, operations

Jan 15, 2025
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Jan 28 -
Jan 29, 2025
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Mar 17 -
Mar 18, 2025
Palo Alto, CA (USA)

Find out more All events

Events

GCVI Summit 2025

Mar 18 -
Mar 20, 2025
Monterey, CA (USA)

Find out more All events

Events

GCV Institute: CVC Investment Programs

Apr 8 -
Apr 10, 2025
Online

Find out more All events

Events

GCV Institute: Landing the Value of Corporate Venturing

Apr 24 -
Jun 12, 2025
Online

Find out more All events

Events

GCV Symposium 2025

Jun 17 -
Jun 19, 2025
London (UK)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.